Oncology biotech CytoMed sees stock fall 10% after $10M IPO (GDTC)

CytoMed Therapeutics (GDTC) stock closed flat following the Asian biotech group's $10M initial public offering, which was priced at the lower end of its range. Read more here.

Related Keywords

Malaysia ,Singapore ,Mikko Lemola , ,Public Offering ,Amed Therapeutics ,